[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))

C208H152N16O2Pd4S2Si4 — CID 159559455

IUPAC[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))
SMILESCn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(oc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(sc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6oc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6sc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.[Pd+2].[Pd+2].[Pd+2].[Pd+2]
InChIInChI=1S/2C52H38N4OSi.2C52H38N4SSi.4Pd/c1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;;;;/h4*4-32H,1-3H3;;;;/q4*-2;4*+2
InChIKeyNLYYEFUAMDBVLI-UHFFFAOYSA-N
MW3509.77 g/mol
LogP39.41
Rot. Bonds24

About [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))

[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) (PubChem CID 159559455) has the molecular formula C208H152N16O2Pd4S2Si4 and a molecular weight of 3509.77 g/mol. Its IUPAC name is [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)).

Molecular Properties

Compound Name[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))
PubChem CID159559455
Molecular FormulaC208H152N16O2Pd4S2Si4
Molecular Weight3509.77 g/mol
Exact Mass3504.69
IUPAC Name[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))
SMILESCn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(oc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(sc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6oc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6sc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.[Pd+2].[Pd+2].[Pd+2].[Pd+2]
InChIInChI=1S/2C52H38N4OSi.2C52H38N4SSi.4Pd/c1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;;;;/h4*4-32H,1-3H3;;;;/q4*-2;4*+2
InChIKeyNLYYEFUAMDBVLI-UHFFFAOYSA-N
XLogP39.41
TPSA162.08 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds24
Heavy Atoms236
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003509.77
LogP ≤ 539.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))?
The IUPAC name of [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) (CID 159559455) is [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)).
What is the SMILES notation for [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))?
The canonical SMILES for [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) is Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(oc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6c(sc7ccccc76)c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6oc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c([Si](c3[c-]c(N4c5ccc6sc7ccccc7c6c5C(C)(C)c5cccnc54)ccc3)(c3ccccc3)c3ccccc3)ccc2)nc2ccccc21.[Pd+2].[Pd+2].[Pd+2].[Pd+2].
What is the InChIKey of [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))?
The InChIKey is NLYYEFUAMDBVLI-UHFFFAOYSA-N. The full InChI is InChI=1S/2C52H38N4OSi.2C52H38N4SSi.4Pd/c1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;1-52(2)43-26-16-32-53-51(43)56(46-31-30-42-41-25-10-13-29-47(41)57-49(42)48(46)52)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-44-27-11-12-28-45(44)55(50)3;1-52(2)42-26-16-32-53-51(42)56(45-30-31-47-48(49(45)52)41-25-10-13-29-46(41)57-47)36-18-15-24-40(34-36)58(37-19-6-4-7-20-37,38-21-8-5-9-22-38)39-23-14-17-35(33-39)50-54-43-27-11-12-28-44(43)55(50)3;;;;/h4*4-32H,1-3H3;;;;/q4*-2;4*+2.
What are the key properties of [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+))?
[3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) has a molecular weight of 3509.77 g/mol, XLogP of 39.41, 24 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(21,21-dimethyl-3-oxa-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-oxa-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-3-thia-14,16-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;[3-(21,21-dimethyl-9-thia-14,16-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-14-yl)benzene-2-id-1-yl]-[3-(1-methylbenzimidazol-2-yl)benzene-2-id-1-yl]-diphenylsilane;tetrakis(palladium(2+)) is sourced from PubChem (CID 159559455), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).